Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/05/21 16:22
2015/05/21 16:22
6d
Take Wednesday's IsoRay announcement about the publication of a study involving use of the company's seed brachytherapy product Cesium-131 to treat patients with early-stage lung cancer after surgery....
2015/05/21 16:22
2015/05/21 16:22
Latest videos
2015/05/21 12:22
2015/05/21 12:22
6d
CAMBRIDGE, Mass. (TheStreet) -- Bluebird Bio's(BLUE - Get Report) gene therapy administered once to a patient with sickle cell anemia is increasing the number of normally functioning red blood cells...
2015/05/19 11:22
2015/05/19 11:22
8d
The speculation of another hepatitis C-related acquisition took off Monday afternoon, sparked by a rumor that Gilead executives canceled a scheduled Tuesday presentation at a health care investor...
2015/05/18 16:22
2015/05/18 16:22
9d
SUMMIT, NJ (TheStreet) -- Mongersen is one of Celgene's(CELG - Get Report) most important pipeline drugs and a potential blockbuster treatment for Crohn's disease, an autoimmune disorder affecting the...
2015/05/13 21:22
2015/05/13 21:22
14d
Abstract 5565 describes a phase II study of selinexor in patients with advanced ovarian, endometrial and cervical cancers no longer responding to prior therapies. The overall response rate for 30...
2015/05/13 21:22
2015/05/13 21:22
14d
Patients in the study continue to be followed for overall survival. Mild infusion-related reactions to elotuzumab were recorded in 10% of patients. Other common side effects including neutropenia and...
2015/05/12 12:22
2015/05/12 12:22
15d
Vertex is counting on the new therapy, known as Orkambi, to deliver billions of dollars in sales and sustainable profits for the first time. Orkambi combines Vertex's already-approved drug Kalydeco...
2015/05/12 10:22
2015/05/12 10:22
15d
The odds are now higher that NewLink's HyperAcute Pancreas vaccine will prove to be failure once a final survival analysis is conducted later this year or in early 2016. NewLink tried to put a...
2015/05/08 16:22
2015/05/08 16:22
19d
Remember a few years back when Gilead Sciences(GILD) shares under-performed on investor worries about a looming patent cliff for its core HIV drug business? Then, Gilead bought Pharmasset for $11...
2015/05/08 16:22
2015/05/08 16:22
19d
VALENCIA, Calif. (TheStreet) -- MannKind's(MNKD) first-quarter conference call on Friday morning didn't go well. Management admitted the Afrezza commercial launch is slower than expected. Cash burn...
2015/05/06 13:22
2015/05/06 13:22
21d
The cash and stock deal values Synageva at $230 per share, based on Alexion's average closing price for the past nine days. That's a 140% premium to Synageva's closing price of $95.87 on...
2015/05/01 13:22
2015/05/01 13:22
26d
The FDA is convening a panel of outside experts on May 12 to review Vertex's combination therapy for cystic fibrosis, which now goes by the brand name Orkambi. I've learned from experience (sometimes...
2015/04/30 11:22
2015/04/30 11:22
27d
Afrezza sales reported by Sanofi presumably includes inventory stocking, but the company did not break down the results further. Sanofi began selling Afrezza in early February. In today's dollars,...
2015/04/28 16:22
2015/04/28 16:22
29d
Like drisapersen, Sarepta's eteplirsen filing is hardly pristine, so again, an FDA advisory panel meeting is all but guaranteed. Will FDA bring together DMD experts for a single meeting to review...
2015/04/28 12:22
2015/04/28 12:22
29d
Opdivo is Bristol's checkpoint inhibitor drug approved for the treatment of melanoma and lung cancer. Sales in the first quarter totaled $40 million, missing the Street's consensus target of $50...
2015/04/27 01:22
2015/04/27 01:22
30d
SAN DIEGO (TheStreet) -- Celladon(CLDN) said Sunday that its experimental gene therapy for heart failure, Mydicar, was a total bust. To its credit, management was fully transparent about the mid-stage...
2015/04/24 16:22
2015/04/24 16:22
m
... Dap is not FDA approved but it's been widely recognized as an effective treatment for LEMS for more than 20 years. Doctors treating the small numbers of LEMS patients in the U.S. can obtain...
2015/04/23 14:22
2015/04/23 14:22
m
The positive effect of idebenone in DMD patients was supported by other measures of lung function, delays in the onset of lung infections and relative improvement in cough strength. Transient but mild...
2015/05/21 16:22
2015/05/21 16:22
Latest from Twitter